The 2 major changes since those days are: 1) back then PIQ thought they were both a scientific/development company and a commercial company. They now realise they are a scientific and development co. 2) the global diagnostic labs have had a huge shift post Covid. They have had an enormous capacity increase thrust upon them to deal with the Covid testing volumes. That capacity is now idle. They made huge sums of money from Covid to now deploy. And, they have huge holes in their earnings.
The Sonic deal (Sonic operates in 8 countries) in the US will hopefully be the first of many with Sonic.
The UK deal looks fantastic with a potential royalty of $100 per test to PIQ.They recently announced they are in discussions with same co to expand to more countries in Europe. Companies and management evolve. The Board back then was also pretty sleepy and that has also been upgraded.
A lot to dislike about the past and a lot to like about the present and future.
PIQ Price at posting:
99.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)